Dopamine, the Kidney and Essential Hypertension Studies with Gludopa

References

• Lee M. R. Dopamine and the Kidney. Clin. Sci. 1982; 62: 439–448
   PubMed Web of Science ®Google Scholar
• Lee M. R. Dopamine and the Kidney. Advances in Renal Physiology, C. J. Lote. Croom Helm, London and Sydney 1978; 218–246, Chapter 7
   Google Scholar
• Bell C., Lang W. J., Laska R. Dopamine Containing Vasomotor Nerves in the Dog Kidney. J. Neurochem. 1978; 31: 77–83
   PubMed Web of Science ®Google Scholar
• Brown M. J., Allison D. J. Renal Conversion of Plasma Dopa to Urine Dopamine. Brit. J. Clin. Pharmacol. 1981; 12: 251–253
   PubMed Web of Science ®Google Scholar
• Fox M., Thiers S., Rosenberg L., Segal S. Ionic Requirements for Aminoacid Transport in the Rat Kidney Cortex Slice. Biochem. Biophys. Acta 1964; 79: 167–176
   PubMed Web of Science ®Google Scholar
• Ullrich K. J., Rumrich G., Kloss S. Sodium Dependence of the Aminoacid Transport in the Proximal Convolution of the Rat Kidney. Pflügers Arch. 1974; 351: 49–60
   PubMed Web of Science ®Google Scholar
• Lovenberg W., Weissbach H., Udenfriend S. Aromatic L-Aminoacid Decarboxylase. J. Biol. Chem. 1962; 237: 89–93
   PubMed Web of Science ®Google Scholar
• Goldberg L. I. Cardiovascular and Renal Actions of Dopamine: Potential Clinical Applications. Pharmacol. Rev. 1972; 24: 1–29
   PubMed Web of Science ®Google Scholar
• Ball S. G., Oates N. S., Lee M. R. Urinary Dopamine in Man and Rat: Effects of Inorganic Salts on Dopamine Excretion. Clin. Sci. Molec. Med. 1978; 55: 167–173
   PubMedGoogle Scholar
• Oates N. S. Studies on Renal Dopamine in Man and the Rat. Ph. D. Thesis, University of Leeds. 1979; 44–64
   Google Scholar
• Oates N. S., Ball S. G., Perkins C. M., Lee M. R. Plasma and Urine Dopamine in Man given Sodium Chloride in the Diet. Clin. Sci. 1979; 56: 261–264
   PubMed Web of Science ®Google Scholar
• Ball S. G., Lee M. R. The Effect of Carbidopa Administration on Urinary Sodium Excretion in Man. Is Dopamine an Intrarenal Natriuretic Hormone?. Brit. J. Clin. Pharmacol. 1977; 4: 115–119
   PubMed Web of Science ®Google Scholar
• Oates N. S., Perkins C. M., Lee M. R. The Effect of Mineralocorticoid Administration on Urine Free Dopamine in Man. Clin. Sci. 1980; 58: 77–82
   PubMed Web of Science ®Google Scholar
• Frederickson E. D., Bradley T., Goldberg L. I. Blockade of Dopamine Induced Natriuresis with a Selective DA1 Antagonist. Clin. Res. 1984; 32: 480 A
   Google Scholar
• McNay J. L., McDonald R. H., Jr, Goldberg L. I. Direct Renal Vasodilation Produced by Dopamine in the Dog. Circ. Res. 1965; 16: 510–517
   PubMed Web of Science ®Google Scholar
• Worth D. P., Harvey J. N., Brown J., Worral A., Lee M. R. Domperidone Treatment in Man Inhibits the Fall in Plasma Renin Activity Induced by Intravenous y-L-glutamyl-L-dopa. Brit. J. Clin. Pharmacol. 1986; 21: 497–502
   PubMed Web of Science ®Google Scholar
• Kent Keeton T., Campbell W. B. The Pharmacologic Alteration of Renin Release. Pharmacol. Rev. 1981; 31(2)86–128
   Google Scholar
• Casson I. F., Lee M. R., Brownjohn A. M., Parsons F. M., Davison A. M., Will E. J., Clayden A. D. Failure of Renal Dopamine Response to Salt Loading in Chronic Renal Disease. Brit. Med. J. 1983; 286: 503–506
   PubMed Web of Science ®Google Scholar
• Warren D. J., Ferris T. F. Renin Secretion in Renal Hypertension. Lancet 1970; 1: 159–162
   PubMed Web of Science ®Google Scholar
• Itskovitz H. D., Gilberg N. Renal Function and Patterns of Catecholamine Excretion. Kidney. Int. 1981; 19: 168
   Web of Science ®Google Scholar
• Perkins C. M., Hancock K. W., Cope G. F., Lee M. R. Urine Dopamine in Normal and Hypertensive Pregnancies. Brit. J. Obstet. Gynaecol. 1982; 89: 123–127
   PubMedGoogle Scholar
• Harvey J. N., Casson I. F., Clayden A. D., Cope G. F., Perkins C. M., Lee M. R. A Paradoxical Fall in Urine Dopamine Output when Patients with Essential Hypertension are given Added Dietary Salt. Clin. Sci. 1984; 67: 83–88
   PubMed Web of Science ®Google Scholar
• Shikuma R., Kambara S., Yoshimura M, et al. Dopaminergic Modulation of Salt Sensitivity in Essential Hypertension. Nippon Jinzo Gakkai. 1984; 26: 417–423
   PubMedGoogle Scholar
• Wilk S., Mizoguchi H., Orlowski M. y-L-glutamyl-L-dopa: A Kidney Specific Dopamine Precursor. J. Pharm. Exp. Ther. 1978; 206: 227–232
   PubMed Web of Science ®Google Scholar
• Casson I. F., Anderson C. K., Cope G. F., Lee M. R. The Effect of Dietary Sodium Chloride and y-glutamyl Dopa on Tubular Necrosis Following Glycerol Administration in the Rat. Brit. J. Exp. Path. 1982; 63: 426–431
   PubMed Web of Science ®Google Scholar
• Casson I. F., Clayden A. D., Cope G. F., Lee M. R. The Protective Effect of y-glutamyl L-dopa on the Glycerol Treated Rat Model of Acute Renal Failure. Clin. Sci. 1983; 65: 159–164
   PubMed Web of Science ®Google Scholar
• Worth D. P., Lee M. R. Comparison of Equimolar Doses of Gludopa and L-dopa in Man. 1986, Submitted for publication
   Google Scholar
• Jeffrey R. F., MacDonald T. M., Brown J., Lee M. R. Studies with y-glutamyl-L-dopa and y-glutamyl-L-tyrosine in Man: Relationships to Intrarenal Dopamine Production and Natriuresis. Proceedings of the Gent Meeting. 1986
   Google Scholar
• MacDonald T. M., Lee M. R. The Natriuretic Effect of Gludopa in Man is Blocked by D-sulpiride. 1986, Submitted for publication
   Google Scholar
• Worth D. P., Harvey J. N., Brown J., Lee M. R. Patients with Essential Hypertension have an Exaggerated Natriuretic Response to the Dopamine Pro-drug Glutamyl-Dopa. J. Hypertension 1985; 3(Suppl. 3)S179–S181
   Google Scholar
• Kikuchi K., Miyama A., Nakao T, et al. Haemodynamic and Natriuretic Responses to Intravenous Infusion of Dopamine in Patients with Essential Hypertension. Jpn. Circ. J. 1982; 46: 486–493
   PubMedGoogle Scholar
• Casson I. F. Studies on the Role of Dopamine in Renal Failure. MD. Thesis, University of Leeds. 1984; 214–234
   Google Scholar
• Critchley J. A. J.H., Cooper E. S., Boye G. L., Johnston N. R., Samson R. R., Lee M. R. Sodium/Dopamine Relationships in the Urine of White Caucasians and Negroid Africans Living in Edinburgh, British Pharmacological Society. Hatfield Meeting. September, 1986
   Google Scholar
• Saito I., Takeshita E., Saruta T., Nagano S., Sekihara T. Urinary Dopamine Excretion in Normotensive Subjects With or Without Family History of Hypertension. J. Hypertension 1986; 4: 57–60
   PubMed Web of Science ®Google Scholar
• Lee M. R. The Kidney Fault in Essential Hypertension may be a Failure to Mobilize Renal Dopamine Adequately when Dietary Sodium Chloride is Increased. Cardiovasc. Revs. and Reports 1981; 2(No. 8)785–789
   Google Scholar
• Stamler J., Stamler R., Reidlinger W. F., Algera G., Roberts R. H. Hypertension Screening of One Million Americans. JAMA. 1976; 235: 2299–2306
   PubMed Web of Science ®Google Scholar
• Helmer O. M., Judson W. E. Metabolic Studies in Hypertensive Patients with Suppressed Plasma Renin Activity not due to Hyperaldosteronism. Circulation 1968; 38: 965–976
   PubMed Web of Science ®Google Scholar
• Dallas Hall W. Pharmacologic Therapy of Hypertension in Blacks. Hypertension in Blacks, W. D. Hall, E. Saunders, N. B. Shulman. Year Book Publishers Inc., Chicago 1985; 182–208, Chapter 13
   Google Scholar
• Harvey J. N., Worth D. P., Brown J., Lee M. R. Studies with Fenoldopam, a Dopamine Receptor DA1 Agonist, in Essential Hypertension. Brit J. Clin. Pharmacol. 1986; 21: 53–61
   PubMed Web of Science ®Google Scholar